سیکلوفسفامید (Cyclophosphamide)
۸۹ محصول ثبت‌شده نسخه‌ای ANDANDA
خلاصهٔ ثبت FDA
- فرم‌های دارویی
- INJECTABLE;INJECTION · CAPSULE;ORAL · SOLUTION;INTRAVENOUS
- دوزهای ثبت‌شده
- 500MG/VIAL · 1GM/VIAL · 2GM/VIAL · 50MG
- شرکت‌های دارنده
- BAXTER HLTHCARE · TEVA PARENTERAL · BEDFORD · HIKMA
- پروندهٔ رسمی
- 012142
محصولات ثبت‌شده (نمایش ۸۰ از ۸۹)
| نام محصول | فرم | دوز | شرکت | نوع | وضعیت | پرونده |
|---|---|---|---|---|---|---|
| CYTOXAN | TABLET;ORAL | 50MG | BAXTER HLTHCARE | NDA | نسخه‌ای | 012141 |
| CYTOXAN | TABLET;ORAL | 25MG | BAXTER HLTHCARE | NDA | نسخه‌ای | 012141 |
| CYTOXAN | INJECTABLE;INJECTION | 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| CYTOXAN | INJECTABLE;INJECTION | 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| CYTOXAN (LYOPHILIZED) | INJECTABLE;INJECTION | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| CYTOXAN (LYOPHILIZED) | INJECTABLE;INJECTION | 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| CYTOXAN (LYOPHILIZED) | INJECTABLE;INJECTION | 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| LYOPHILIZED CYTOXAN | INJECTABLE;INJECTION | 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| LYOPHILIZED CYTOXAN | INJECTABLE;INJECTION | 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| CYTOXAN (LYOPHILIZED) | INJECTABLE;INJECTION | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| CYTOXAN (LYOPHILIZED) | INJECTABLE;INJECTION | 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| CYTOXAN (LYOPHILIZED) | INJECTABLE;INJECTION | 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | BAXTER HLTHCARE | NDA | متوقف‌شده | 012142 |
| NEOSAR | INJECTABLE;INJECTION | 100MG/VIAL | TEVA PARENTERAL | ANDA | متوقف‌شده | 040015 |
| NEOSAR | INJECTABLE;INJECTION | 200MG/VIAL | TEVA PARENTERAL | ANDA | متوقف‌شده | 040015 |
| NEOSAR | INJECTABLE;INJECTION | 500MG/VIAL | TEVA PARENTERAL | ANDA | متوقف‌شده | 040015 |
| NEOSAR | INJECTABLE;INJECTION | 1GM/VIAL | TEVA PARENTERAL | ANDA | متوقف‌شده | 040015 |
| NEOSAR | INJECTABLE;INJECTION | 2GM/VIAL | TEVA PARENTERAL | ANDA | متوقف‌شده | 040015 |
| CYCLOPHOSPHAMIDE | TABLET;ORAL | 25MG | ROXANE | ANDA | متوقف‌شده | 040032 |
| CYCLOPHOSPHAMIDE | TABLET;ORAL | 50MG | ROXANE | ANDA | متوقف‌شده | 040032 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | BAXTER HLTHCARE | ANDA | نسخه‌ای | 040745 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | BAXTER HLTHCARE | ANDA | نسخه‌ای | 040745 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 2GM/VIAL | BAXTER HLTHCARE | ANDA | نسخه‌ای | 040745 |
| NEOSAR | INJECTABLE;INJECTION | 100MG/VIAL | BEDFORD | ANDA | متوقف‌شده | 087442 |
| NEOSAR | INJECTABLE;INJECTION | 200MG/VIAL | BEDFORD | ANDA | متوقف‌شده | 087442 |
| NEOSAR | INJECTABLE;INJECTION | 500MG/VIAL | BEDFORD | ANDA | متوقف‌شده | 087442 |
| NEOSAR | INJECTABLE;INJECTION | 1GM/VIAL | BEDFORD | ANDA | متوقف‌شده | 087442 |
| NEOSAR | INJECTABLE;INJECTION | 2GM/VIAL | BEDFORD | ANDA | متوقف‌شده | 087442 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 100MG/VIAL | BAXTER HLTHCARE | ANDA | متوقف‌شده | 088371 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 200MG/VIAL | BAXTER HLTHCARE | ANDA | متوقف‌شده | 088372 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | BAXTER HLTHCARE | ANDA | متوقف‌شده | 088373 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | BAXTER HLTHCARE | ANDA | متوقف‌شده | 088374 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | HIKMA | NDA | نسخه‌ای | 203856 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | HIKMA | NDA | نسخه‌ای | 203856 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | HENGRUI PHARMA | ANDA | نسخه‌ای | 204555 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | HENGRUI PHARMA | ANDA | نسخه‌ای | 204555 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 2GM/VIAL | HENGRUI PHARMA | ANDA | نسخه‌ای | 204555 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | ANI PHARMS | ANDA | متوقف‌شده | 207014 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | ANI PHARMS | ANDA | متوقف‌شده | 207014 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | PHARMAZONE | ANDA | نسخه‌ای | 209872 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | PHARMAZONE | ANDA | نسخه‌ای | 209872 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | AMNEAL | ANDA | نسخه‌ای | 210046 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | AMNEAL | ANDA | نسخه‌ای | 210046 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 2GM/VIAL | AMNEAL | ANDA | نسخه‌ای | 210046 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 500MG/2.5ML (200MG/ML) | EUGIA PHARMA SPECLTS | NDA | نسخه‌ای | 210735 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 1GM/5ML (200MG/ML) | EUGIA PHARMA SPECLTS | NDA | نسخه‌ای | 210735 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 2GM/10ML (200MG/ML) | EUGIA PHARMA SPECLTS | NDA | نسخه‌ای | 210735 |
| FRINDOVYX | SOLUTION;INTRAVENOUS | 500MG/ML (500MG/ML) | AVYXA HOLDINGS | NDA | نسخه‌ای | 210852 |
| FRINDOVYX | SOLUTION;INTRAVENOUS | 1GM/2ML (500MG/ML) | AVYXA HOLDINGS | NDA | نسخه‌ای | 210852 |
| FRINDOVYX | SOLUTION;INTRAVENOUS | 2GM/4ML (500MG/ML) | AVYXA HOLDINGS | NDA | نسخه‌ای | 210852 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | AMNEAL PHARMS | ANDA | نسخه‌ای | 210890 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | AMNEAL PHARMS | ANDA | نسخه‌ای | 210890 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | ZYDUS LIFESCIENCES | ANDA | نسخه‌ای | 211552 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | ZYDUS LIFESCIENCES | ANDA | نسخه‌ای | 211552 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | CIPLA | ANDA | نسخه‌ای | 211608 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | CIPLA | ANDA | نسخه‌ای | 211608 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | XGEN PHARMS | ANDA | نسخه‌ای | 211757 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | XGEN PHARMS | ANDA | نسخه‌ای | 211757 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 2GM/VIAL | XGEN PHARMS | ANDA | نسخه‌ای | 211757 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 500MG/2.5ML (200MG/ML) | DR REDDYS | NDA | نسخه‌ای | 212501 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 1GM/5ML (200MG/ML) | DR REDDYS | NDA | نسخه‌ای | 212501 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 2GM/10ML (200MG/ML) | DR REDDYS | NDA | نسخه‌ای | 212501 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | SAGENT PHARMS INC | ANDA | نسخه‌ای | 214529 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | SAGENT PHARMS INC | ANDA | نسخه‌ای | 214529 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 2GM/VIAL | SAGENT PHARMS INC | ANDA | نسخه‌ای | 214529 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | SUNNY | ANDA | نسخه‌ای | 215089 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | SUNNY | ANDA | نسخه‌ای | 215089 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 2GM/VIAL | SUNNY | ANDA | نسخه‌ای | 215089 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | ALEMBIC | ANDA | نسخه‌ای | 215892 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | ALEMBIC | ANDA | نسخه‌ای | 215892 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 500MG/2.5ML (200MG/ML) | NEXUS | ANDA | نسخه‌ای | 216783 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 1GM/5ML (200MG/ML) | NEXUS | ANDA | نسخه‌ای | 216783 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 500MG/VIAL | HIKMA | ANDA | نسخه‌ای | 216958 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 1GM/VIAL | HIKMA | ANDA | نسخه‌ای | 216958 |
| CYCLOPHOSPHAMIDE | INJECTABLE;INJECTION | 2GM/VIAL | HIKMA | ANDA | نسخه‌ای | 216958 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 500MG/5ML (100MG/ML) | SANDOZ | NDA | نسخه‌ای | 217150 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 1GM/10ML (100MG/ML) | SANDOZ | NDA | نسخه‌ای | 217150 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 2GM/20ML (100MG/ML) | SANDOZ | NDA | نسخه‌ای | 217150 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 500MG/2.5ML (200MG/ML) | BAXTER HLTHCARE CORP | NDA | نسخه‌ای | 217651 |
| CYCLOPHOSPHAMIDE | SOLUTION;INTRAVENOUS | 1GM/5ML (200MG/ML) | BAXTER HLTHCARE CORP | NDA | نسخه‌ای | 217651 |
| CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | EIRGEN | ANDA | نسخه‌ای | 218282 |
این پرونده از کجا می‌آید؟
داده‌ها از فایل‌های رسمی Drugs@FDA data files (Products، Applications و MarketingStatus) گرفته شده‌اند. هر ردیف جدول یک محصول ثبت‌شده با همان مادهٔ مؤثره است؛ شمارهٔ پرونده به صفحهٔ رسمی FDA لینک دارد. وضعیت «متوقف‌شده» یعنی محصول دیگر توزیع نمی‌شود.
خبر دارو و سلامت را
از دست ندهید
روزی چند گزارش کوتاه، بدون تبلیغ و بدون اسپم.